Clinical Research Facility
Advanced Therapies Manufacturing (GMP) Platform
Biostatistics and Data Management Platform
Flow Cytometry Platform
Translational Bioinformatics Platform
Clinical Trials Management Platform
Flow Cytometry and Immune Monitoring Platform: A state-of-the-art laboratory allowing researchers to carry out immune monitoring on samples taken from volunteers and patients. It provides investigators with equipment and support for cell sorting, acquisition and analysis of flow cytometric data.
NIHR Guy’s and St Thomas’ Clinical Research Facility: Ideal for clinicians, researchers and allied health professionals looking to conduct patient and volunteer studies. We have four CRF Units including MHRA accredited Phase I, Cardiometabolic, Paediatric and Imaging
Genomics Platform: Supports the discovery of novel approaches to the prevention, diagnosis and therapy of major diseases. A range of services is offered to clinical and academic investigators working with the ultimate aim of improving patient outcomes.
Advanced Therapy Manufacturing Platform: The GMP (Good Manufacturing Practice) Unit provides a flexible space for the production of cell and gene therapies for clinical trials. The unit enables the use in studies of Advanced Therapy Medicinal Products (ATMPs), which have heralded a new era in patient care and treatment.
Translational Bioinformatics Platform: Focuses on translational projects designed to identify novel therapeutic targets and disease biomarkers. Also enables the dissection of molecular mechanisms underpinning diseases and aims to support the application of advanced bioinformatics analyses in scientific projects.
Biostatistics and Data Management Platform: The platform, led by Professor Janet Peacock and Dr Catey Bunce works collaboratively with researchers across clinical disciplines on all aspects relating to biostatistics and data management.
Clinical Trials Management Platform: Our clinical trials managers can assist with the day-to-day operational management of trials and are central to their successful completion.